Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Dec 18;13(1):159.
doi: 10.1186/s13102-021-00383-0.

Sustained acoustic medicine for the treatment of musculoskeletal injuries: a systematic review and meta-analysis

Affiliations
Free PMC article

Sustained acoustic medicine for the treatment of musculoskeletal injuries: a systematic review and meta-analysis

Sandra L Winkler et al. BMC Sports Sci Med Rehabil. .
Free PMC article

Abstract

Background: Musculoskeletal injuries account for 10 million work-limited days per year and often lead to both acute and/or chronic pain, and increased chances of re-injury or permanent disability. Conservative treatment options include various modalities, nonsteroidal anti-inflammatory drugs, and physical rehabilitation programs. Sustained Acoustic Medicine is an emerging prescription home-use mechanotransductive device to stimulate cellular proliferation, increase microstreaming and cavitation in situ, and to increase tissue profusion and permeability. This research aims to summarize the clinical evidence on Sustained Acoustic Medicine and measurable outcomes in the literature.

Methods: A systematic literature review was conducted using PubMed, EBSCOhost, Academic Search Complete, Google Scholar and ClinicalTrials.gov to identify studies evaluating the effects of Sustained Acoustic Medicine on the musculoskeletal system of humans. Articles identified were selected based on inclusion criteria and scored on the Downs and Black checklist. Study design, clinical outcomes and primary findings were extracted from included studies for synthesis and meta-analysis statistics.

Results: A total of three hundred and seventy-two participants (372) were included in the thirteen clinical research studies reviewed including five (5) level I, four (4) level II and four (4) level IV studies. Sixty-seven (67) participants with neck and back myofascial pain and injury, one hundred and fifty-six (156) participants with moderate to severe knee pain and radiographically confirmed knee osteoarthritis (Kellgren-Lawrence grade II/III), and one hundred forty-nine (149) participants with generalized soft-tissue injury of the elbow, shoulder, back and ankle with limited function. Primary outcomes included daily change in pain intensity, change in Western Ontario McMaster Osteoarthritis Questionnaire, change in Global Rate of Change, and functional outcome measures including dynamometry, grip strength, range-of-motion, and diathermic heating (temperature measurement).

Conclusion: Sustained Acoustic Medicine treatment provides tissue heating and tissue recovery, improved patient function and reduction of pain. When patients failed to respond to physical therapy, Sustained Acoustic Medicine proved to be a useful adjunct to facilitate healing and return to work. As a non-invasive and non-narcotic treatment option with an excellent safety profile, Sustained Acoustic Medicine may be considered a good therapeutic option for practitioners.

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
A Ultrasound increases cellular proliferation, tissue regeneration, and vascularity. These mechanisms are active daily over 4 h to upregulate healing, reduce inflammation and pain. B Ultrasound increases capillary permeability, increase nutrient exchange, oxygenation, and matrix relaxation at the site of injury, C ultrasound increases the vasodilation (vessels diameter), oxygenation, blood flow, and extends collagen fibers matrix
Fig. 2
Fig. 2
PRISMA flow diagram for identification, screening, eligibility and included articles in SAM clinical study analysis
Fig. 3
Fig. 3
Forest plot of pain and health improvement measures comparing SAM Treatment vs. placebo A SAM treatment provides significant reduction of pain (p = 0.005). B SAM provides significant improvement in health quality (p < 0.00001)
Fig. 4
Fig. 4
Forest plot of knee Osteoarthritis pain reduction from SAM Treatment vs. placebo. SAM treatment provides significant reduction of pain (p < 0.00001)
Fig. 5
Fig. 5
Forest plot of ultrasound diathermy tissue heating with SAM Treatment vs. placebo. SAM treatment provides significant temperature increase of soft-tissue (p < 0.00001)
Fig. 6
Fig. 6
The future application of SAM treatment. A Ultrasound thermal and acoustic properties can improve local drug delivery, improve wound and bone healing and reduce arthritis progression. B Ultrasound treatment may reduce the progression of osteoarthritis by reducing the rate of osteophyte formation and inflammatory cell activation

Similar articles

References

    1. Airaksinen O, Brox JI, Cedraschi C, Hildebrandt J, Klaber-Moffett J, Kovacs F, et al. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J. 2006;15(2):S192–300. - PMC - PubMed
    1. El-Tallawy SN, Nalamasu R, Salem GI, LeQuang JAK, Pergolizzi JV, Christo PJ. Management of musculoskeletal pain: an update with emphasis on chronic musculoskeletal pain. Pain Ther. 2021;10(1):181–209. - PMC - PubMed
    1. Brief report: Morbidity burdens attributable to illnesses and injuries in deployed (per Theater Medical Data Store [TMDS]) compared to nondeployed (per Defense Medical Surveillance System [DMSS]) settings, active component, US Armed Forces, 2010. MSMR. 2011;18(11):14–5. - PubMed
    1. Yelin E, Weinstein S, King T. The burden of musculoskeletal diseases in the United States. Semin Arthritis Rheum. 2016;46(3):259–260. - PubMed
    1. Yelin E, Weinstein S, King T. An update on the burden of musculoskeletal diseases in the U.S. Semin Arthritis Rheum. 2019;49(1):1–2. - PubMed